Please login to the form below

Not currently logged in


This page shows the latest Gazyvo news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Imbruvica and Gazyvo approved in first non-chemo CLL use Imbruvica and Gazyvo approved in first non-chemo CLL use

    Further boost for blockbuster leukaemia drug. B lockbuster leukaemia drug Imbruvica has extended its reach again, gaining FDA approval for combination use with Gazyvo in first-line use in chronic lymphocytic ... The approval is also good news for Roche

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...